Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccines against STDs: specific considerations?

H Wigzell1

  • 1Department of Immunology, Karolinska Institute, Stockholm, Sweden.

Scandinavian Journal of Infectious Diseases. Supplementum
|January 1, 1990
PubMed
Summary

Vaccine development for sexually transmitted infectious diseases (STDs) faces challenges, but no unique obstacles block vaccine efficacy. Research indicates exaggerated infection parameters in STDs, including HIV/AIDS, require specific vaccine strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Professor emeritus Jacob B. Natvig, one of the founders of Scandinavian journal of immunology, turns 75.

Scandinavian journal of immunology·2009
Same author

Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.

International journal of immunogenetics·2008
Same author

T cell receptor V gene usage by CD4+ and CD8+ peripheral blood T lymphocytes in immune thrombocytopenic purpura.

Acta paediatrica (Oslo, Norway : 1992)·2004
Same author

Hsp90 binds CpG oligonucleotides directly: implications for hsp90 as a missing link in CpG signaling and recognition.

Cellular and molecular life sciences : CMLS·2003
Same author

Adjuvant modulation of the immune responses and the outcome of infection with Chlamydia pneumoniae.

Clinical and experimental immunology·2002
Same author

Lung restricted T cell receptor AV2S3+ CD4+ T cell expansions in sarcoidosis patients with a shared HLA-DRbeta chain conformation.

Thorax·2002

Area of Science:

  • Immunology
  • Infectious Diseases
  • Vaccinology

Background:

  • Sexually transmitted infectious diseases (STDs) pose a significant global health threat.
  • The emergence of Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) has amplified the importance of STDs.
  • Understanding immune system responses to STDs is crucial for vaccine development.

Purpose of the Study:

  • To evaluate potential unique challenges posed by STDs to vaccine efficacy.
  • To assess the feasibility of developing effective vaccines against various STDs.
  • To specifically examine obstacles in creating a vaccine for HIV.

Main Methods:

  • Literature review and analysis of immunological parameters in STD infections.
  • Comparative assessment of immune responses to different STDs.
  • Case study focusing on vaccine development challenges for HIV.

Main Results:

  • Certain infection parameters are significantly exaggerated in STDs.
  • No unique or insurmountable obstacles were identified that inherently prevent vaccine function against STDs.
  • Developing an effective HIV vaccine presents specific, complex challenges.

Conclusions:

  • Vaccines can potentially be effective against STDs, despite exaggerated infection parameters.
  • Standard vaccine approaches may require adaptation for STDs.
  • HIV vaccine development remains a critical and complex area requiring further research.

Related Experiment Videos